Drug recall D-0573-2022
Product
Methylphenidate Hydrochloride Chewable Tablets, 2.5 mg, 100-count bottle, Rx Only, Manufactured for: Rising Pharmaceuticals Inc., Saddle Brook, NJ 07863, NDC 64980-221-01
Reason for recall
Failed Tablet Specifications: Recall of this drug product was voluntarily initiated by the manufacturer due to a market complaint, which stated that a tablet in the sealed bottle was twice larger in size when compared to the remaining tablets. This complaint is second of its kind.
Lots and codes
lot# 25910009, Exp 01/2023
Recall details
- Recalling firm
- RISING PHARMACEUTICALS, East Brunswick, NJ
- Quantity
- 2220 100-count bottles
- Distribution
- Nationwide in the USA
- Type
- Voluntary: Firm initiated
- Recall initiated
- February 7, 2022
Related products
- Methylphenidate Hydrochloride – drug information
- NDC 64980-222 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 5 mg/1 · Rising Pharma Holdings, Inc.
- NDC 64980-223 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 10 mg/1 · Rising Pharma Holdings, Inc.
- NDC 64980-221 Methylphenidate Hydrochloride · Methylphenidate Hydrochloride 2.5 mg/1 · Rising Pharma Holdings, Inc.